MYVTAMA
LIVE

Serial Number

97591262

Owner

Dermavant Sciences GmbH

Attorney

Joyce M. Ferraro

Filing Date

Sep 14, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MYVTAMA Trademark

Serial Number: 97591262 • Registration: 7657097

MYVTAMA is a trademark filed by Dermavant Sciences GmbH on September 14, 2022. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Dermavant Sciences GmbH (12 trademarks)

Viaduktstrasse 8
4051 Basel , CH

Entity Type: 99

Trademark Details

Filing Date

September 14, 2022

Registration Date

January 21, 2025

Published for Opposition

December 3, 2024

Goods & Services

Printed products, namely, lists featuring a registry of patients with atopic dermatitis, acne, psoriasis, skin related diseases, disorders and conditions for medical treatment purposes

Patient support services, namely, financial administration of patient reimbursement programs via a website and telecommunications networks

Patient consumer support, namely, providing consumer product information in the field of pharmaceuticals via a website and telecommunications networks; patient support services, namely, business administration of patient reimbursement programs via a website and telecommunications networks

Providing medical information; Providing a website and an Internet website portal featuring a registry of patients with atopic dermatitis, acne, psoriasis, skin related diseases, disorders and conditions for medical treatment purposes; providing medical and health information to consumers, patients, doctors, and caregivers in the field of atopic dermatitis, acne, psoriasis, skin related diseases, disorders and conditions

Medical and scientific research services; providing information in the field of medical and scientific research featuring a registry of patients with atopic dermatitis, acne, psoriasis, skin related diseases, disorders and conditions; administering a scientific advisory committee in the nature of providing scientific advice and scientific consultation relating to atopic dermatitis, acne, psoriasis, skin related diseases, disorders and conditions; hosting an online community website featuring shared communications between community members in the field of atopic dermatitis, acne, psoriasis, skin related diseases, disorders and conditions; providing an online community for users to engage with and share information in the field of atopic dermatitis, acne, psoriasis, skin related diseases, disorders and conditions

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 21, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 21, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2024 NONP
EXPARTE APPEAL TERMINATED
Nov 4, 2024 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 4, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 26, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 25, 2024 ERFR
EX PARTE APPEAL-INSTITUTED
Sep 25, 2024 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Sep 25, 2024 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Sep 25, 2024 EXAF
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 24, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 24, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 25, 2024 GNFN
FINAL REFUSAL E-MAILED
Mar 25, 2024 GNFR
FINAL REFUSAL WRITTEN
Mar 25, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2024 CRFA
ASSIGNED TO LIE
Feb 26, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 4, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 6, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 6, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jul 6, 2023 CNRT
TEAS VOLUNTARY AMENDMENT RECEIVED
Jun 29, 2023 PARI
ASSIGNED TO EXAMINER
Jun 26, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 19, 2022 NWOS
NEW APPLICATION ENTERED
Sep 17, 2022 NWAP